Development of Zika Virus Vaccines
Zika virus (ZIKV) is a mosquito-borne flavivirus that emerged as a global threat following the most recent outbreak in Brazil in 2015. ZIKV infection of pregnant women is associated with fetal abnormalities such as microcephaly, and infection of adults can lead to Guillain–Barré syndrome, an autoimm...
Main Authors: | Huda Makhluf, Sujan Shresta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/6/1/7 |
Similar Items
-
Immune Responses to Dengue and Zika Viruses—Guidance for T Cell Vaccine Development
by: Claude Roth, et al.
Published: (2018-02-01) -
In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations
by: Lorrany dos Santos Franco, et al.
Published: (2017-11-01) -
Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development
by: Annie Elong Ngono, et al.
Published: (2019-06-01) -
Zika virus: Vaccine initiatives and obstacles
by: Reema Mukherjee, et al.
Published: (2017-01-01) -
Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade
by: Jin Sun, et al.
Published: (2020-03-01)